MedHexim1
MedHexim1 focuses on Hexim1 as a biomarker and drug design target as strategy to develop a diagnostic test and therapy for prostate cancer. MedHexim1 Team: Eduardo Mascareno, PhD, President Manya Dhar-Mascareno, President
Read MoreBrooklyn Biologics
Brooklyn Biologics — Our product is a novel formulation of protein and lipids, enabling in vitro/in vivo transfection with DNA/siRNA/miRNA at higher efficiency rates. Brooklyn Biologics Team: Carlo Yuvienco, PhD, Co-Founder Joseph Frezzo Jin Montclare
Read MoreHyperfine
Hyperfine – My company/technology is advanced analytics software for personalized medicine – the goal for my company is to assist in the creation of cures. Hyperfine Team: Bridget Osetinksy, CEO Bobby Mannepalli, COO
Read MoreZakan Theraputics
Zakan Therapeutics — A biological therapeutic that can directly attack metastatic cancer cells by delivering a payload of anti-cancer compounds while bypassing healthy cells. Zakan Theraputics Team: Arthee Jahangir Benjamin Caballero
Read MoreTaithera, Inc.
Aithera is a revolutionary nanomedicine bone targeted drug delivery controlled release platform technology for the treatment of musculoskeletal conditions focused initially on fracture healing & bone cancer (osteosarcoma is our first oncology target). Aithera Team: Seth Harlem, CEO Mo Chen, PhD, CSO
Read MoreAision Biotechnologies
Prophylactic drugs that protect against depression and PTSD in a vaccine-like fashion. Rebecca Brachman, Co-Founder Christine Denny, PhD, Co-Founder
Read MoreIchor Biologics
A validated platform for the isolation of human monoclonal antibodies (mAbs), which neutralize emerging and re-emerging infectious diseases. Ichor Biologics Team: Raymond Alvarez Justin Ring
Read MoreInnovene, Inc.
Innovene has designed a new class of medications from safe plant-derived components; TriCurin will target the unmet medical need of treating patients with oncogenic human papillomavirus infections. Innovene Team: Mario Castellanos, MD, Co-Founder and President Alia Kozlova
Read MoreBioharmony Therapy
Bioharmony Therapeutics is an early-stage biotech startup focused on the development of first-in-class antimicrobials that target infections caused by Gram-negative bacteria. Bioharmony Theraputics Team: Chandrabali Ghose-Paul, Founder and CEO
Read MoreArdent
Ardent has developed technologies to transform “energy-storing” white adipose tissue (WAT) into “energy-burning” brown adipose tissue (BAT) for treatment of obesity, diabetes, and metabolic disease. Team: Luis Santos Brian Gillette
Read More